ProQR Therapeutics Sets Annual Shareholder Meeting for June 3
Ticker: PRQR · Form: 6-K · Filed: May 1, 2025 · CIK: 1612940
| Field | Detail |
|---|---|
| Company | Proqr Therapeutics N.V. (PRQR) |
| Form Type | 6-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
ProQR sets AGM for June 3rd, shareholders get updates.
AI Summary
ProQR Therapeutics N.V. announced on May 1, 2025, that its Annual General Meeting of Shareholders will be held on June 3, 2025. The company also made certain information available to its shareholders.
Why It Matters
Shareholder meetings are crucial for corporate governance, allowing investors to vote on important company matters and hear updates directly from management.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a shareholder meeting and does not contain new financial or operational risks.
Key Players & Entities
- ProQR Therapeutics N.V. (company) — Registrant
- June 3, 2025 (date) — Date of Annual General Meeting of Shareholders
- May 1, 2025 (date) — Date of press release
FAQ
What is the purpose of the Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed by ProQR Therapeutics N.V. pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
When will ProQR Therapeutics N.V.'s Annual General Meeting of Shareholders be held?
The Annual General Meeting of Shareholders will be held on June 3, 2025.
What event did ProQR Therapeutics N.V. announce on May 1, 2025?
On May 1, 2025, ProQR Therapeutics N.V. issued a press release announcing its Annual General Meeting of Shareholders to be held on June 3, 2025.
Does ProQR Therapeutics N.V. file annual reports under Form 20-F or Form 40-F?
ProQR Therapeutics N.V. indicates that it files annual reports under cover of Form 20-F.
What is the principal executive office address of ProQR Therapeutics N.V.?
The principal executive offices are located at Zernikedreef 9, 2333 CK Leiden, The Netherlands.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 1, 2025 regarding ProQR Therapeutics N.V. (PRQR).